Search research articles
Contact Us
Filters
Showing results (151-160 of 164) with videos related to
Page
of 17
Sort By:
British Journal of Cancer
|
April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E Bignotti, M Ragnoli, L Zanotti, et al.
Journal of the American Chemical Society
|
May 24, 2016
Bithiophenesulfonamide Building Block for π-Conjugated Donor-Acceptor Semiconductors
Ferdinand S Melkonyan, Wei Zhao, Martin Drees, et al.
The Journal of Experimental Medicine
|
December 19, 2001
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction
A Dzionek, Y Sohma, J Nagafune, et al.
The Journal of Pathology
|
June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
S Tedoldi, J C Paterson, J Cordell, et al.
British Journal of Haematology
|
June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma
C Tecchio, G Nadali, P Scapini, et al.
Virchows Archiv : an International Journal of Pathology
|
August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Leukemia
|
January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
A Dodero, A Guidetti, A Tucci, et al.
Pathologica
|
September 8, 2012
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue
H Rizvi, J C Paterson, S Tedoldi, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 164) with videos related to
Sort By:
Page
of 17
British Journal of Cancer
|
April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E Bignotti, M Ragnoli, L Zanotti, et al.
Journal of the American Chemical Society
|
May 24, 2016
Bithiophenesulfonamide Building Block for π-Conjugated Donor-Acceptor Semiconductors
Ferdinand S Melkonyan, Wei Zhao, Martin Drees, et al.
The Journal of Experimental Medicine
|
December 19, 2001
BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction
A Dzionek, Y Sohma, J Nagafune, et al.
The Journal of Pathology
|
June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
S Tedoldi, J C Paterson, J Cordell, et al.
British Journal of Haematology
|
June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma
C Tecchio, G Nadali, P Scapini, et al.
Virchows Archiv : an International Journal of Pathology
|
August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology
|
October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit
Arianna Di Napoli, D Remotti, C Agostinelli, et al.
The Journal of Pathology
|
October 16, 2007
Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
S Tedoldi, A Mottok, J Ying, et al.
Leukemia
|
January 12, 2019
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
A Dodero, A Guidetti, A Tucci, et al.
Pathologica
|
September 8, 2012
Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue
H Rizvi, J C Paterson, S Tedoldi, et al.
Page
of 17